On January 8, 2020 Roivant Sciences reported that Vivek Ramaswamy, Founder and Chief Executive Officer of Roivant, reported that it will present an overview of recent developments and future directions for the business at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco, CA (Press release, Roivant Sciences, JAN 8, 2020, View Source [SID1234552885]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The company’s presentation is scheduled to begin at 10:30 a.m. PT on Tuesday, January 14, 2020 at the Westin St. Francis.

Roivant recently announced the close of its transaction forming a strategic alliance with Sumitomo Dainippon Pharma. The company will discuss this transaction and other business updates during its presentation.